Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding

Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding

Texas is making history by funding a major ibogaine research initiative with an unprecedented sum. As the United States continues to grapple with an increasing rate of mental health conditions, the need for efficacious new treatment modalities is immense.

This is particularly true among the American veterans community. Depression, PTSD, and substance use disorders resulting from those conditions are alarmingly prevalent. So is suicide, unfortunately.

On Thursday, a press release credited to the Texas ...

Continue Reading →

Ibogaine By David Dardashti to Share Groundbreaking Ibogaine Treatment Protocol Insights, Including for Neurodegenerative Conditions and Diabetes, at Psychedelic Science 2025 in Denver

DENVER, CO – May 21, 2025 – Ibogaine By David Dardashti, will be hosting a booth at the upcoming Psychedelic Science 2025 conference, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS). The conference, a premier global gathering for psychedelic research, medicine, policy, and culture, will take place from June 16-20, 2025, at the Colorado Convention ...

Continue Reading →

Texas set to fund first clinical studies of psychedelic drug to treat PTSD

Texas is set to become one of the biggest players in psychedelics research, as the Legislature is poised to fund the first clinical trials of a drug lawmakers hope will eventually help reduce veteran suicide rates and offer an alternative to opioid treatments. 

Both chambers of the state Legislature have approved ...

Continue Reading →
Page 59 of 136 «...3040505758596061...»
UA-77446339-1